Zum Hauptinhalt springen

Hepatitiden

22. Mai 2025 | Hepatitiden

Multiple approaches to genetic sequencing to identify hepatitis C virus reinfection among people who inject drugs,

Multiple approaches to genetic sequencing to identify hepatitis C virus reinfection among people who inject drugs, Kyra H Grantz, Raghavendran Anantharam, Abraham J Kandathil, Jeffrey Quinn, Jacqueline Astemborski, Gregory D Kirk, Oluwaseun F…

16. Mai 2025 | Hepatitiden

Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial.

Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial. Cooke GS, Hung LM, Flower B, McCabe L, Hang VTK, Thu VT, Thuan DT, Dung NT, Phuong LT, Khoa DB, An NTC, Thach…

08. Mai 2025 | Hepatitiden

Approaches to Offering Hepatitis C Treatment at Syringe Services Programs in the United States: A Scoping Review.

Approaches to Offering Hepatitis C Treatment at Syringe Services Programs in the United States: A Scoping Review. Yoder T, Hirose K, Tsui JI, Feinberg J, Hagan H, Pho MT, Rowan SE. Open Forum Infect Dis. 2025 Apr 8;12(4):ofaf211. doi: 10.109…

08. Mai 2025 | Hepatitiden

Current drug use patterns and HIV and HCV prevalence among people who inject drugs in suburban areas of Malaysia.

Current drug use patterns and HIV and HCV prevalence among people who inject drugs in suburban areas of Malaysia. Pang J, Danaee M, Balasingam Kasinather V, Des Jarlais D, Kamarulzaman A, Mohd Salleh NA. J Int AIDS Soc. 2025 May;28(5)…

08. Mai 2025 | Hepatitiden

Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among People Who Use Drugs in Turkey.

Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among People Who Use Drugs in Turkey. Asan A, Turan C, Senormanci O, Sayar MS, Metin S, Hakyemez IN. Open Forum Infect Dis. 2025 Mar 13;12(4):ofaf…

08. Mai 2025 | Hepatitiden

Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran.

Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran. Khezri M, Tavakoli F, Mehmandoost S, Sharafi H, Zamani O, Bazrafshani MS, Nasiri N, Mirzaei H, Moameri H, Haghdoost AA…

08. Mai 2025 | Hepatitiden

Direct-acting antivirals (DAA) positively affect depression and cognitive function in patients with chronic hepatitis C.

Direct-acting antivirals (DAA) positively affect depression and cognitive function in patients with chronic hepatitis C. Pawłowski T, Radkowski M, Perlejewski K, Szymańska B, Berak H, Horban A, et al. (2025) PLoS ONE 20(4): e0320221. d…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten